Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Versartis reports data from ongoing extension study of VRS-317 for growth hormone deficiency

Jan. 8, 2015

Seikagaku reports new cathepsin K inhibitors

Jan. 8, 2015

Kowa divulges insulin secretagogues

Jan. 8, 2015

Alnylam files application for phase I trial of ALN-AS1

Jan. 7, 2015

Manufacturing and distribution approval for selective SGLT2 inhibitor for diabetes

Jan. 7, 2015

NephroGenex successfully completes QT study of Pyridorin

Jan. 5, 2015

Ampla Pharmaceuticals describes GPBAR1 agonists

Jan. 2, 2015

Repros initiates phase IIb studies of Proellex for uterine fibroids

Jan. 2, 2015

Palatin initiates phase III program for bremelanotide in female sexual dysfunction

Jan. 2, 2015

Alexion completes rolling BLA submission to the FDA for asfotase alfa

Dec. 31, 2014

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 10, 2026.
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026
Hematopoietic stem cell research points to leukemia’s early roots
BioWorld
Hematopoietic stem cell research over the past century has shown that leukemia may be driven by an invisible hand of inflammation. The bone marrow and...
Korsana boosts Alzheimer’s work with reverse merger, $380M financing
BioWorld Science
Just over a month after emerging from stealth and disclosing a $150 million series A, Korsana Biosciences Inc. is making the leap to the public market via a...